Development and evaluation of a low-cost, portable, LED-based device for PDT treatment of early-stage oral cancer in resource-limited settings

被引:39
作者
Liu, Hui [1 ]
Daly, Liam [2 ]
Rudd, Grant [2 ]
Khan, Amjad P. [3 ]
Mallidi, Srivalleesha [3 ]
Liu, Yiran [1 ]
Cuckov, Filip [2 ]
Hasan, Tayyaba [3 ]
Celli, Jonathan P. [1 ]
机构
[1] Univ Massachusetts, Dept Phys, 100 Morrisey Blvd, Boston, MA 02125 USA
[2] Univ Massachusetts, Dept Engn, Boston, MA 02125 USA
[3] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA
关键词
photodynamic therapy (PDT); Oral Cancer; light emitting diode (LED); global health; aminolevulinic acid (ALA); protoporphhyrin IX (PpIX); TOPICAL 5-AMINOLEVULINIC ACID; LIGHT-EMITTING DIODE; PHOTODYNAMIC THERAPY; LEUKOPLAKIA; LESIONS;
D O I
10.1002/lsm.23019
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Photodynamic therapy (PDT) using delta-aminolevulinic acid (ALA) photosensitization has shown promise in clinical studies for the treatment of early-stage oral malignancies with fewer potential side effects than traditional therapies. Light delivery to oral lesions can also carried out with limited medical infrastructure suggesting the potential for implementation of PDT in global health settings. Objectives We sought to develop a cost-effective, battery-powered, fiber-coupled PDT system suitable for intraoral light delivery enabled by smartphone interface and embedded electronics for ease of operation. Methods Device performance was assessed in measurements of optical power output, spectral stability, and preclinical assessment of PDT response in ALA-photosensitized squamous carcinoma cell cultures and murine subcutaneous tumor xenografts. Results The system achieves target optoelectronic performance with a stable battery-powered output of approximately 180 mW from the fiber tip within the desired spectral window for PpIX activation. The device has a compact configuration, user friendly operation and flexible light delivery for the oral cavity. In cell culture, we show that the overall dose-response is consistent with established light sources and complete cell death of ALA photosensitized cells can be achieved in the irradiated zone. In vivo PDT response (reduction in tumor volume) is comparable with a commercial 635 nm laser. Conclusions We developed a low-cost, LED-based, fiber-coupled PDT light delivery source that has stable output on battery power and suitable form factor for deployment in rural and/or resource-limited settings. Lasers Surg. Med. 9999:1-7, 2018. (c) 2018 Wiley Periodicals, Inc.
引用
收藏
页码:345 / 351
页数:7
相关论文
共 22 条
[1]  
[Anonymous], SCI REPORT
[2]  
Casiglia Jeffrey, 2001, General Dentistry, V49, P72
[3]   An imaging-based platform for high-content, quantitative evaluation of therapeutic response in 3D tumour models [J].
Celli, Jonathan P. ;
Rizvi, Imran ;
Blanden, Adam R. ;
Massodi, Iqbal ;
Glidden, Michael D. ;
Pogue, Brian W. ;
Hasan, Tayyaba .
SCIENTIFIC REPORTS, 2014, 4
[4]   Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization [J].
Celli, Jonathan P. ;
Spring, Bryan Q. ;
Rizvi, Imran ;
Evans, Conor L. ;
Samkoe, Kimberley S. ;
Verma, Sarika ;
Pogue, Brian W. ;
Hasan, Tayyaba .
CHEMICAL REVIEWS, 2010, 110 (05) :2795-2838
[5]   Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy [J].
Chen, HM ;
Yu, CH ;
Tu, PC ;
Yeh, CY ;
Tsai, T ;
Chiang, CP .
LASERS IN SURGERY AND MEDICINE, 2005, 37 (02) :114-122
[6]   5-Aminolevulinic acid-mediated photodynamic therapy for oral cancers and precancers [J].
Chen, Hsin-Ming ;
Yu, Chuan-Hang ;
Lin, Hung-Pin ;
Cheng, Shih-Jung ;
Chiang, Chun-Pin .
JOURNAL OF DENTAL SCIENCES, 2012, 7 (04) :307-315
[7]   Challenges of the Oral Cancer Burden in India [J].
Coelho, Ken Russell .
JOURNAL OF CANCER EPIDEMIOLOGY, 2012, 2012
[8]   The bystander effect in photodynamic inactivation of cells [J].
Dahle, J ;
Bagdonas, S ;
Kaalhus, O ;
Olsen, G ;
Steen, HB ;
Moan, J .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2000, 1475 (03) :273-280
[9]  
Fan KFM, 1996, CANCER-AM CANCER SOC, V78, P1374
[10]   Cancer revoked: oncogenes as therapeutic targets [J].
Felsher, DW .
NATURE REVIEWS CANCER, 2003, 3 (05) :375-380